Advances in Treatment Decision Making in Ductal Carcinoma in Situ (DCIS)

Dr. David Hyams from Desert Surgical Oncology. Dr. Hyams discusses and fields questions on ductal carcinoma in situ treatment. He also discusses recent advances that can help define recurrence risk and guide treatment decision making. Dr. Hyams has over 25 years of experience and has spent much of his career in academic medicine, serving on the faculty of two well-recognized Universities. In addition to his surgical expertise, Dr. Hyams is an internationally recognized consultant and educator in surgical oncology. Click here for Dr. Hyams’s bio.

CancerConnect is a safe and private way to connect with others in a fully-moderated setting which provides a place for patients and caregivers to share experiences, offer support, and have access to up-to-date and medically reviewed information on liver cancer treatment. Join the conversation now by registering or logging in.